Recently, researchers in Tsinghua University published an article on Nature Communications entitled Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy. They programed oncolytic viruses (OVs) using synthetic gene circuits, thus to improve the specificity of OV treatment and achieve controllability as well as local expression of immune effectors, which aroused the attention to oncolytic virotherapy of the biological world. —
As a leading biotechnology company, Creative Biolabs announces productions and services of one-stop oncolytic virotherapy development, covering a wide range of cancer, such as melanoma, genitourinary, gastrointestinal cancers, hepatocellular carcinoma, gynecologic malignancies, breast cancer, lung cancer, head and neck cancer, brain tumors, etc.
Oncolytic Virotherapy Development for Melanoma
Melanoma is a kind of skin cancer caused by cells named melanocytes. It’s one of the common cancers and of great risk for its ability to spread to other organs more rapidly. In order to promote the application of OVs in the treatment of melanoma, Creative Biolabs has developed an OncoVirapy™ platform, providing a full range of oncolytic virotherapy development service from OV construction to function validation both in vitro and in vivo. In the whole process, scientists of Creative Biolabs will not only care about the antitumor efficacy, but also take safety and other clinical issues into account.
Oncolytic Virotherapy Development for Genitourinary Malignancies
In a review of the top 10 causes of death in men, bladder cancer is eighth and renal cancer is tenth. These two kinds of cancer as well as penis cancer and testicle cancer are all called genitourinary (GU) malignancies. For oncolytic virus development of GU cancers, Creative Biolabs can provide virus vector construction and validation services on the basis of genetic mutations, virus tropism and arming virus. Beyond the aforementioned options, more strategies are available, such as combination of oncolytic virus with gene therapy, coat modification of oncolytic virus, delivery of oncolytic virus with carrier cells.
Oncolytic Virotherapy Development for Gastrointestinal Cancers
Gastrointestinal (GI) cancers refer to malignant conditions of the gastrointestinal tract and organs of digestion. With the need of novel therapeutic strategies, oncolytic virus continues to hold promise as an effective treatment. With accumulated experience, scientists in Creative Biolabs are skillful in developing oncolytic virotherapy for GI cancers, especially for gastric cancer and pancreatic cancer.
Oncolytic Virotherapy Development for Hepatocellular Carcinoma
One of the important aims of antitumor therapies is to target tumor cells selectively and specifically, meantime, sparing adjacent healthy tissue from destruction. Creative Biolabs provides OV with adenoviruses and vesicular stomatitis virus (VSV) as the vector, and gene-edited viruses for the enhanced therapeutic efficacy.
Based on the experienced team consisting of scientists of Ph. D level and dedicated managers, Creative Biolabs are confident in providing novel OVs and developing more efficient oncolytic virotherapy strategies to make a contribution to the OV research of global scientists. Further information can be found on: https://www.creative-biolabs.com/oncolytic-virus.
About Creative Biolabs
With years of study and experience in cancer immunotherapy development and virotherapy, Creative Biolabs, a leading company providing customized, standardized, reliable and high-quality oncolytic virus therapy development services, covering oncolytic virus design and construction, oncolytic virus engineering, in vitro and in vivo validation, and other featured oncolytic virotherapy development services for various type of tumors and for combination with other therapies.
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Release ID: 88936528